Xospata

Xospata (gilteritinib) is an oral prescription medication used to treat certain types of acute myeloid leukemia (AML). It belongs to a class of drugs known as tyrosine kinase inhibitors. This medication helps slow the growth of cancer cells in the body.

Xospata (gilteritinib) is primarily used to treat adults with relapsed or refractory acute myeloid leukemia (AML) who have a specific genetic mutation called FLT3. It works by blocking signals that promote cancer cell growth. This medication is often prescribed when standard treatments have not been effective. Patients may ask, 'what is Xospata used for' or 'how does gilteritinib treat AML'.

Xospata (gilteritinib) is taken orally and works systemically to target cancer cells. Common effects include gastrointestinal discomfort, fatigue, and changes in blood cell counts. Some patients may experience nausea, diarrhea, or swelling in the hands or feet. These effects vary by individual and should be monitored by a healthcare provider.

Xospata should be taken exactly as prescribed by a healthcare professional. It is important to discuss your full medical history, including any liver or kidney conditions, before starting this medication. Regular blood tests are typically required to monitor your body’s response. Avoid grapefruit products while taking Xospata, as they may interact with the drug.

Xospata can interact with other medications, including certain antibiotics, antifungals, and herbal supplements. Strong CYP3A4 inhibitors or inducers may alter how Xospata works in the body. Alcohol and grapefruit products should be avoided due to potential interactions. Always inform your doctor about all medications and supplements you are taking.